RTTNews | Jun 2, 2021 07:19AM EDT

07:19 Wednesday, June 2, 2021 (RTTNews.com) - Liquidia Says FDA Accepted NDA Resubmission For LIQ861 Inhalation Powder To Treat PAH

For comments and feedback: contact editorial@rttnews.com

https://www.rttnews.comCopyright(c) 2021 RTTNews.com All Rights Reserved